MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - TSX:MDA - CA55293N1096 - Common Stock
32.61 CAD
+0.53 (+1.65%)
MDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 12 industry peers in the Aerospace & Defense industry. While MDA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MDA is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make MDA a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
MDA had positive earnings in the past year.
In the past year MDA had a positive cash flow from operations.
Of the past 5 years MDA 4 years were profitable.
Each year in the past 5 years MDA had a positive operating cash flow.
1.2 Ratios
The Return On Assets of MDA (3.63%) is better than 91.67% of its industry peers.
The Return On Equity of MDA (8.94%) is better than 100.00% of its industry peers.
The Return On Invested Capital of MDA (5.72%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for MDA is below the industry average of 8.31%.
The last Return On Invested Capital (5.72%) for MDA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROIC | 5.72% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of MDA (8.48%) is better than 91.67% of its industry peers.
MDA's Profit Margin has improved in the last couple of years.
MDA's Operating Margin of 10.97% is in line compared to the rest of the industry. MDA outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of MDA has grown nicely.
MDA has a Gross Margin of 24.54%. This is in the better half of the industry: MDA outperforms 66.67% of its industry peers.
MDA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
Compared to 1 year ago, MDA has more shares outstanding
The debt/assets ratio for MDA has been reduced compared to a year ago.
2.2 Solvency
MDA has an Altman-Z score of 1.92. This is not the best score and indicates that MDA is in the grey zone with still only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 1.92, MDA belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
MDA has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.55, MDA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.29 indicates that MDA is not too dependend on debt financing.
The Debt to Equity ratio of MDA (0.29) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 1.92 |
ROIC/WACC0.62
WACC9.16%
2.3 Liquidity
MDA has a Current Ratio of 0.86. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
MDA has a Current ratio of 0.86. This is amonst the worse of the industry: MDA underperforms 83.33% of its industry peers.
A Quick Ratio of 0.85 indicates that MDA may have some problems paying its short term obligations.
The Quick ratio of MDA (0.85) is better than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 185.37% over the past year.
The Earnings Per Share has been growing by 185.75% on average over the past years. This is a very strong growth
MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 57.21%.
The Revenue has been growing by 31.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
3.2 Future
The Earnings Per Share is expected to grow by 46.56% on average over the next years. This is a very strong growth
Based on estimates for the next years, MDA will show a very strong growth in Revenue. The Revenue will grow by 23.27% on average per year.
EPS Next Y112.1%
EPS Next 2Y63.75%
EPS Next 3Y46.56%
EPS Next 5YN/A
Revenue Next Year52.35%
Revenue Next 2Y31%
Revenue Next 3Y23.27%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
MDA is valuated quite expensively with a Price/Earnings ratio of 27.87.
MDA's Price/Earnings ratio is in line with the industry average.
MDA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.20.
MDA is valuated rather expensively with a Price/Forward Earnings ratio of 17.37.
MDA's Price/Forward Earnings is on the same level as the industry average.
MDA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.71.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.87 | ||
| Fwd PE | 17.37 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDA.
Based on the Price/Free Cash Flow ratio, MDA is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.8 | ||
| EV/EBITDA | 15.66 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MDA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as MDA's earnings are expected to grow with 46.56% in the coming years.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y63.75%
EPS Next 3Y46.56%
5. Dividend
5.1 Amount
MDA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (9/16/2025, 7:00:00 PM)
32.61
+0.53 (+1.65%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners30.22%
Inst Owner ChangeN/A
Ins Owners1.25%
Ins Owner ChangeN/A
Market Cap4.11B
Analysts78.18
Price Target43.5 (33.39%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)21.08%
Max EPS beat(2)22.16%
EPS beat(4)4
Avg EPS beat(4)29.79%
Min EPS beat(4)19.18%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)31.88%
EPS beat(12)11
Avg EPS beat(12)88.39%
EPS beat(16)14
Avg EPS beat(16)87.43%
Revenue beat(2)1
Avg Revenue beat(2)3.32%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)6.87%
Revenue beat(4)3
Avg Revenue beat(4)3.78%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)3.09%
Revenue beat(12)9
Avg Revenue beat(12)2.82%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)-12.21%
PT rev (3m)22.34%
EPS NQ rev (1m)-2.81%
EPS NQ rev (3m)53.78%
EPS NY rev (1m)24.79%
EPS NY rev (3m)24.79%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)14.49%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)1.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.87 | ||
| Fwd PE | 17.37 | ||
| P/S | 3.04 | ||
| P/FCF | 5.8 | ||
| P/OCF | 4.28 | ||
| P/B | 3.21 | ||
| P/tB | 16.19 | ||
| EV/EBITDA | 15.66 |
EPS(TTM)1.17
EY3.59%
EPS(NY)1.88
Fwd EY5.76%
FCF(TTM)5.62
FCFY17.23%
OCF(TTM)7.63
OCFY23.39%
SpS10.73
BVpS10.17
TBVpS2.01
PEG (NY)0.25
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROCE | 7.95% | ||
| ROIC | 5.72% | ||
| ROICexc | 8.9% | ||
| ROICexgc | 61.78% | ||
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% | ||
| FCFM | 52.35% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexcg growth 3Y59.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 262.11% | ||
| Cap/Sales | 18.71% | ||
| Interest Coverage | 8.48 | ||
| Cash Conversion | 392.53% | ||
| Profit Quality | 617.7% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.92 |
F-Score6
WACC9.16%
ROIC/WACC0.62
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
EPS Next Y112.1%
EPS Next 2Y63.75%
EPS Next 3Y46.56%
EPS Next 5YN/A
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
Revenue Next Year52.35%
Revenue Next 2Y31%
Revenue Next 3Y23.27%
Revenue Next 5YN/A
EBIT growth 1Y115.07%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year177.81%
EBIT Next 3Y52.71%
EBIT Next 5YN/A
FCF growth 1Y1778.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y628.56%
OCF growth 3Y124.48%
OCF growth 5YN/A